KimeraChems.coUse code GUIDE for 10% OFF
Back to Nootropics
Nootropics

CE-123

Shop CE-123 on KimeraChems · code GUIDE (10% off)

Definition

CE-123 is an experimental dopaminergic modulator derived from the modafinil family, investigated for its potential wakefulness-promoting, cognitive-enhancing, and pro-motivational properties. Preclinical data suggest it may selectively influence dopamine transporter (DAT) activity with reduced peripheral stimulation compared to classical stimulants.

Available Formats

  • Dry-fill capsules
  • 5 grams powder

Mechanism of Action

Research indicates CE-123 may: These mechanisms make it of interest in attention, fatigue-resistance, and cognitive-performance research models.

  • Modulate dopamine transporter (DAT) activity
  • Enhance dopaminergic signaling in cognition-related regions
  • Increase wakefulness and attentional performance in preclinical models
  • Support motivation and reward-learning pathways
  • Produce stimulant-like cognitive effects with lower cardiovascular impact than amphetamine-class compounds

Areas of Investigation

CE-123 is commonly explored for its potential roles in

  • Attention and focus studies
  • Cognitive enhancement models
  • Fatigue and sleep-deprivation research
  • Motivation- and reward-learning pathways
  • Neuropsychiatric dopaminergic-system modeling
  • Comparative analysis vs. modafinil derivatives

Safety Profile

Documented observations include: Responses are model-dependent and influenced by dosing strategy.

  • Mild overstimulation
  • Anxiety or jitteriness in dopaminergic-sensitive models
  • Sleep disruption if administered late in the day
  • Irritability or restlessness at elevated doses
  • Head pressure or tension in some subjects

Interaction Notes

CE-123 is commonly explored alongside: Caution is recommended when pairing with

  • Dopaminergic agents: bromantane, tyrosine, selegiline (with caution)
  • Nootropic modulators: Noopept, aniracetam, phenylpiracetam
  • Neuroprotective compounds: Methylene Blue, SS-31
  • Strong stimulants (amphetamine, DMAA, high-dose caffeine)
  • MAO-inhibiting agents
  • Compounds that heavily modulate dopamine or norepinephrine
Disclaimer

For educational purposes only. Not for human consumption.